Koers IR Biosciences Holdings Inc. Other OTC
Aandelen
IRBS
US46264M3034
Biotechnologie & Medisch Onderzoek
Omzet 2009 | - | Omzet 2010 | - | Marktkapitalisatie | 1,2 mln. 1,12 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2009 | -6 mln. -5,6 mln. | Nettowinst (verlies) 2010 | -5 mln. -4,67 mln. | EV/omzet 2009 | - |
Nettoschuld 2009 | 5,81 mln. 5,42 mln. | Nettoschuld 2010 | 3,67 mln. 3,43 mln. | EV/omzet 2010 | - |
K/w-verhouding 2009 |
-0,37
x | K/w-verhouding 2010 |
-0,2
x | Werknemers | - |
Dividendrendement 2009 * |
-
| Dividendrendement 2010 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-07-03 | |
John N. Fermanis
DFI | Director of Finance/CFO | 70 | 01-12-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-07-03 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,80% | 53,67 mld. | |
+34,72% | 38,86 mld. | |
-8,05% | 38,76 mld. | |
-8,98% | 27,27 mld. | |
+10,69% | 25,91 mld. | |
-16,21% | 20,29 mld. | |
+31,00% | 12,78 mld. | |
+28,51% | 12,18 mld. | |
-1,67% | 11,96 mld. |